Financhill
Back

DocuSign, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison

Buy
54

DOCU
DocuSign, Inc.

Last Price:
$65.66
Seasonality Move:
12.2%
Buy
72

KYMR
Kymera Therapeutics, Inc.

Last Price:
$66.69
Seasonality Move:
7.7%
Buy
54
DocuSign, Inc. (DOCU) is a Buy

Is DocuSign, Inc. a Buy, Sell or Hold?

  • The current DocuSign, Inc. [DOCU] share price is $65.67. The Score for DOCU is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • DOCU is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Kymera Therapeutics, Inc. (KYMR) is a Buy

Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Kymera Therapeutics, Inc. [KYMR] share price is $66.62. The Score for KYMR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

DOCU Stock Price Chart

What is DocuSign, Inc.'s stock price today?

  • The DocuSign, Inc. share price today is $65.67
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DOCU is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics, Inc.'s stock price today?

  • The Kymera Therapeutics, Inc. share price today is $66.62
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

DOCU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.45 Sell
Relative Strength Index (14 RSI): 41.52 Sell
Chaikin Money Flow: 2428374 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (65.97 - 70.93) Sell
Bollinger Bands (100): (67.83 - 78.89) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.78 Buy
Relative Strength Index (14 RSI): 60.29 Buy
Chaikin Money Flow: 254539 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.36 - 66.56) Buy
Bollinger Bands (100): (43.77 - 61.91) Buy

DOCU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.85 Sell
20-day SMA: 67.68 Sell
50-day SMA: 69.74 Sell
200-day SMA: 77.21 Sell
8-day EMA: 68.35 Sell
20-day EMA: 68.39 Sell
50-day EMA: 70.22 Sell
200-day EMA: 74.63 Sell

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 66.47 Buy
20-day SMA: 64.83 Buy
50-day SMA: 61.21 Buy
200-day SMA: 43.96 Buy
8-day EMA: 66.09 Buy
20-day EMA: 64.75 Buy
50-day EMA: 60.61 Buy
200-day EMA: 48.97 Buy

DocuSign, Inc. Earnings Growth & DOCU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.01 per share, an increase this year of $0.66 per share, and an increase next year of $0.24 per share.

Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.

DocuSign, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):